Evidence map›Paper›PMID 37676044›Full record

ArticleMicrobiology spectrum2023

Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single-cell RNA sequencing.

Phillip Cohen, Emma J DeGrace, Oded Danziger, Roosheel S Patel, Erika A Barrall, Tesia Bobrowski, Thomas Kehrer, Anastija Cupic, Lisa Miorin, Adolfo García-Sastre and 1 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Single-Cell RNA-Sequencing of RVFV Infection.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Phillip CohenDepartment of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.ORCID 0000-0002-9368-5154
Emma J DeGraceDepartment of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
Oded DanzigerDepartment of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
Roosheel S PatelDepartment of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
Erika A BarrallDepartment of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
Tesia BobrowskiDepartment of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
Thomas KehrerDepartment of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
Anastija CupicDepartment of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
Lisa MiorinDepartment of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.
Brad R RosenbergDepartment of Microbiology, Icahn School of Medicine at Mount Sinai , New York, New York, USA.ORCID 0000-0002-5885-1276
Icahn School of Medicine at Mount Sinai · US

Funding

NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00014 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2021 to 2025
$62.6M
SARS-CoV adaptations through a Systems Biology Lens (SYBIL)U19AI135972 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Adolfo Garcia-Sastre · 2018 to 2026
$27.2M
Technology Development Project - Increasing the complexity of ex vivo human airway models for studying immune response to viral infectionU19AI142733 · NIAID · JACKSON LABORATORY · PI Damien Chaussabel · 2019 to 2026
$23.1M
MOUNT SINAI MEDICAL SCIENTIST TRAINING PROGRAMT32GM007280 · NIGMS · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BARON, MARGARET H · 1985 to 2021
$22.8M
TRAINING PROGRAM: MECHANISMS OF VIRUS-HOST INTERACTIONST32AI007647 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI Domenico Tortorella · 2000 to 2026
$11.5M
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody AnalysesU54CA260560 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SHYR, YU · 2020 to 2024
$10.0M
Dynamic regulatory network models of human response to influenza virusU01AI150748 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI MARAZZI, IVAN, MIRALDI, EMILY · 2020 to 2024
$5.8M
Next Generation Resolution of Antiviral Gene NetworksR01AI151029 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Dusan Bogunovic, Brad Rosenberg · 2020 to 2026
$4.2M
COVID and Translational Science supercomputer (CATS)S10OD030463 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2021 to 2021
$2.0M
Big Omics Data Engine 2 SupercomputerS10OD026880 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2019 to 2019
$2.0M
Rhinovirus C Infection in Normal and Asthmatic Human Airway Epithelium at Single Cell ResolutionR21AI149180 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI ROSENBERG, BRAD, SCULL, MARGARET ADELE · 2020 to 2021
$461k
HHS | NIH | National Cancer Institute (NCI) CA260560HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI135972HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI142733HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI150748HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI151029NCI NIH HHS U54 CA260560NIAID NIH HHS 75N93021C00014NIAID NIH HHS R01 AI151029NIAID NIH HHS R21 AI149180NIAID NIH HHS T32 AI007647NIAID NIH HHS U01 AI150748NIAID NIH HHS U19 AI135972NIAID NIH HHS U19 AI142733NIGMS NIH HHS T32 GM007280NIH HHS S10 OD026880NIH HHS S10 OD030463
6 · The paper itself

Abstract

importanceSingle-cell RNA sequencing (scRNA-Seq) has emerged as a valuable tool to study host-virus interactions, especially for coronavirus disease 2019 (COVID-19). Here we compare the performance of different scRNA-Seq library preparation methods and sequencing strategies to detect SARS-CoV-2 RNAs and develop a data processing workflow to quantify unambiguous sequence reads derived from SARS-CoV-2 genomic RNA and subgenomic mRNAs. After establishing a workflow that maximizes the detection of SARS-CoV-2 subgenomic mRNAs, we explore patterns of SARS-CoV-2 gene expression across cells with variable levels of total viral RNA, assess host gene expression differences between infected and bystander cells, and identify non-canonical and lowly abundant SARS-CoV-2 RNAs. The sequencing and data processing strategies developed here can enhance studies of coronavirus RNA biology at single-cell resolution and thereby contribute to our understanding of viral pathogenesis.

Indexed as

coronavirusmolecular methodssingle-cell RNA-seqtranscriptomicsviral pathogenesisvirologyvirus-host interactions

Identifiers

PMID37676044
PMCPMC10580996
OpenAlexW4386509090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.